Skip to main content

Drug Interactions between fluconazole and Levaquin

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

fluconazole levoFLOXacin

Applies to: fluconazole and Levaquin (levofloxacin)

MONITOR: In one case report, coadministration of fluconazole and levofloxacin was suspected in causing QT prolongation and torsade de pointes ventricular arrhythmia. The exact mechanism of interaction is unknown, although both agents have individually been associated with these events on rare occasions. The case patient was a 53-year-old man who was being managed for possible nosocomial pneumonia and received intravenous levofloxacin for 8 doses over 14 days and intravenous fluconazole for 2 doses over 2 days before developing torsade de pointes. His QTc interval was 655 ms and remained prolonged for 12 days after resolution of the arrhythmia, despite discontinuation of both medications and substitution with caspofungin. His medical history includes paroxysmal atrial fibrillation, chronic obstructive pulmonary disease, type I diabetes mellitus, and hemodialysis-dependent diabetic nephropathy. Electrolyte imbalance and prior medications were ruled out as possible causes. However, the patient may have received more fluconazole than intended due to inadvertent administration on a day he did not receive dialysis.

MANAGEMENT: Caution is advised if fluconazole is coadministered with levofloxacin. Patients should be advised to seek medical attention if they experience symptoms that could indicate the occurrence of torsade de pointes such as dizziness, palpitations, or syncope.

References

  1. Wassmann S, Nickenig G, Bohm M (1999) "Long QT syndrome and Torsade de Pointes in a patient receiving fluconazole." Ann Intern Med, 131, p. 797
  2. Samaha FF (1999) "QTC interval prolongation and polymorphic ventricular tachycardia in association with levofloxacin." Am J Med, 107, p. 528-9
  3. Tholakanahalli VN, Potti A, Hanley JF, Merliss AD (2001) "Fluconazole-induced torsade de pointes." Ann Pharmacother, 35, p. 432-4
  4. Frothingham R (2001) "Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin." Pharmacotherapy, 21, p. 1468-72
  5. Khazan M, Mathis AS (2002) "Probable case of torsades de pointes induced by fluconazole." Pharmacotherapy, 22, p. 1632-7
  6. Gandhi PJ, Menezes PA, Vu HT, Rivera AL, Ramaswamy K (2003) "Fluconazole- and levofloxacin-induced torsades de pointes in an intensive care unit patient." Am J Health Syst Pharm, 60, p. 2479-83
View all 6 references

Switch to consumer interaction data

Drug and food interactions

Moderate

levoFLOXacin food

Applies to: Levaquin (levofloxacin)

ADJUST DOSING INTERVAL: Food may reduce the oral absorption and bioavailability of levofloxacin. According to the drug product labeling, administration of levofloxacin 500 mg with food prolonged the time to peak concentration by 1 hour and decreased the Cmax decreased by 25% following administration of the oral solution and by 14% following administration of the oral tablet.

MANAGEMENT: To ensure maximal and consistent oral absorption, levofloxacin oral solution should be taken at least one hour before or two hours after meals. For administration of the oral solution with continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for one hour before and two hours after the dose of levofloxacin. The oral tablets may be taken without regard to food.

References

  1. Wohlt PD, Zheng L, Gunderson S, Balzar SA, Johnson BD, Fish JT (2009) "Recommendations for the use of medications with continuous enteral nutrition." Am J Health Syst Pharm, 66, p. 1438-67

Switch to consumer interaction data

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.


Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.